AI Article Synopsis

  • The study examines the role of PPARγ in hepatic ischemia/reperfusion injury (HIRI), a common complication in liver surgery, which remains poorly understood.
  • Administration of PPARγ agonist rosiglitazone showed protective effects against liver injury, inflammation, and oxidative stress in mice and cell models, while silencing PPARγ exacerbated damage.
  • The findings suggest that PPARγ's protective mechanism involves the inhibition of NF-κB signaling, which is activated when PPARγ levels are reduced.

Article Abstract

Background: Hepatic ischemia/reperfusion injury (HIRI) is an unavoidable complication in liver surgery, however its pathological process is still unclear. Therefore, in this study, the role and mechanism of peroxisome proliferator-activated receptor gamma (PPARγ) was investigated in HIRI.

Materials And Methods: We constructed mice models with HIRI and L02 cell models insulted hypoxia/re-oxygenation (H/R). PPARγ agonist rosiglitazone was administered prior to HIRI in mice and PPARγ-siRNA was to H/R treatment in L02 cells. Liver injury was measured by serum ALT, AST and LDH levels and performing H&E staining; the inflammatory injury was reflected by inflammatory markers IL-1β, IL-6 and TNF-α, which were assayed by Real-time PCR and Western blotting, MPO activity was determined using commercial kits; oxidative stress injury was evaluated by iNOS, MDA, SOD and GSH-PX levels; apoptosis was detected by cleaved-Caspase-3, TUNEL staining and flow cytometry; NF-κB signaling activation was reflected by phosphorylation of IκBα (p-IκBα) and nuclear translocation of NF-κB p65.

Results: The level of PPARγ expression was obviously down-regulated both in mice liver subjected to IRI and in L02 cells to H/R. Overexpression of PPARγ presented protective effect on HIRI by reducing serum levels of aminotransferase and hepatic necrosis, inhibiting inflammation and apoptosis and alleviating oxidative stress in vivo. But PPARγ-siRNA aggravate H/R insult by promoting inflammation and apoptosis in vitro. Mechanistically, the NF-κB pathway activity was increased with PPARγ down-regulation by PPARγ-siRNA. Importantly, inhibition of NF-κB signaling abolished PPARγ knockdown-mediated hepatic injury.

Conclusions: PPARγ present protective effects on HIRI by attenuating liver injury, inflammatory response, oxidative stress and apoptosis in vivo and in vitro, and its mechanism may be related to down-regulation of NF-κB signaling.

Download full-text PDF

Source
http://dx.doi.org/10.1080/08941939.2022.2090033DOI Listing

Publication Analysis

Top Keywords

oxidative stress
12
nf-κb signaling
12
pparγ
8
hepatic ischemia/reperfusion
8
ischemia/reperfusion injury
8
nf-κb pathway
8
l02 cells
8
liver injury
8
inflammation apoptosis
8
injury
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!